$FTLF
FITLIFE BRANDS, INC.

2024 Q4 Form 10-Q Financial Statement

#000143774924035027 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $15.98M
YoY Change 14.93%
Cost Of Revenue $8.976M
YoY Change 9.38%
Gross Profit $7.001M
YoY Change 22.91%
Gross Profit Margin 43.82%
Selling, General & Admin $2.645M
YoY Change -16.61%
% of Gross Profit 37.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.00K
YoY Change 36.36%
% of Gross Profit 0.21%
Operating Expenses $3.819M
YoY Change 18.38%
Operating Profit $3.182M
YoY Change 28.83%
Interest Expense -$286.0K
YoY Change -214.86%
% of Operating Profit -8.99%
Other Income/Expense, Net -$286.0K
YoY Change -15.88%
Pretax Income $2.896M
YoY Change 35.96%
Income Tax $770.0K
% Of Pretax Income 26.59%
Net Earnings $2.126M
YoY Change 25.35%
Net Earnings / Revenue 13.31%
Basic Earnings Per Share $0.46
Diluted Earnings Per Share $0.43
COMMON SHARES
Basic Shares Outstanding 4.598M 4.598M
Diluted Shares Outstanding 4.965M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.664M
YoY Change -36.48%
Cash & Equivalents $4.720M
Short-Term Investments
Other Short-Term Assets $998.0K
YoY Change -43.17%
Inventory $10.37M
Prepaid Expenses
Receivables $2.008M
Other Receivables $58.00K
Total Short-Term Assets $18.10M
YoY Change -7.31%
LONG-TERM ASSETS
Property, Plant & Equipment $91.00K
YoY Change -54.27%
Goodwill $13.13M
YoY Change -1.43%
Intangibles $26.31M
YoY Change 239.71%
Long-Term Investments
YoY Change
Other Assets $522.0K
YoY Change -82.82%
Total Long-Term Assets $40.49M
YoY Change 65.63%
TOTAL ASSETS
Total Short-Term Assets $18.10M
Total Long-Term Assets $40.49M
Total Assets $58.59M
YoY Change 33.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.078M
YoY Change 71.42%
Accrued Expenses $1.046M
YoY Change -45.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $4.500M
YoY Change 80.0%
Total Short-Term Liabilities $12.06M
YoY Change 63.17%
LONG-TERM LIABILITIES
Long-Term Debt $9.664M
YoY Change 10.45%
Other Long-Term Liabilities $352.0K
YoY Change 496.61%
Total Long-Term Liabilities $9.664M
YoY Change 10.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.06M
Total Long-Term Liabilities $9.664M
Total Liabilities $24.43M
YoY Change 30.48%
SHAREHOLDERS EQUITY
Retained Earnings $3.497M
YoY Change -171.41%
Common Stock $46.00K
YoY Change 4.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.16M
YoY Change
Total Liabilities & Shareholders Equity $58.59M
YoY Change 33.24%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $2.126M
YoY Change 25.35%
Depreciation, Depletion And Amortization $15.00K
YoY Change 36.36%
Cash From Operating Activities $2.047M
YoY Change 109.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.125M
YoY Change 80.0%
NET CHANGE
Cash From Operating Activities 2.047M
Cash From Investing Activities 0.000
Cash From Financing Activities -1.125M
Net Change In Cash 922.0K
YoY Change -162.38%
FREE CASH FLOW
Cash From Operating Activities $2.047M
Capital Expenditures $0.00
Free Cash Flow $2.047M
YoY Change 110.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52369
dei Entity Address Address Line1
EntityAddressAddressLine1
5214 S. 136th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Omaha
dei Entity Address State Or Province
EntityAddressStateOrProvince
NE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
68137
dei City Area Code
CityAreaCode
402
dei Local Phone Number
LocalPhoneNumber
991-5618
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
FTLF
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4598241
CY2023Q4 us-gaap Cash
Cash
1139000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2046000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
162000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
9091000 usd
CY2023Q4 ftlf Sales Taxes Receivable
SalesTaxesReceivable
1019000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
639000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14693000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
113000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26309000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
13294000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
792000 usd
CY2023Q4 us-gaap Assets
Assets
55346000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4598000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4598000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39401000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8206000 usd
dei Entity Registrant Name
EntityRegistrantName
FITLIFE BRANDS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3464383
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31043000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3497000 usd
CY2024Q3 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
-428000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
34158000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58587000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15977000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13902000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
49456000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8976000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27588000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
7001000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
5696000 usd
us-gaap Gross Profit
GrossProfit
21868000 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1093000 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1275000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3647000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2645000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1897000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7681000 usd
CY2023Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
32000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
217000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
85000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3819000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3226000 usd
us-gaap Operating Expenses
OperatingExpenses
11630000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2470000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
10238000 usd
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
19000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
119000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
41000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
326000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
249000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1085000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
21000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-210000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
26000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-286000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-340000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1018000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2896000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2130000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9220000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
770000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
434000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2126000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1696000 usd
us-gaap Net Income Loss
NetIncomeLoss
6914000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.5
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.4
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4598000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4446000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4598000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4891000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4943000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2126000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1696000 usd
us-gaap Net Income Loss
NetIncomeLoss
6914000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2161000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1378000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6778000 usd
us-gaap Net Income Loss
NetIncomeLoss
6914000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
85000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000 usd
us-gaap Inventory Write Down
InventoryWriteDown
-76000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
344000 usd
ftlf Amortization Of Deferred Finance Costs
AmortizationOfDeferredFinanceCosts
31000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1223000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-270000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-793000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
827000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-82000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
680000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8653000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1898000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1105000 usd
us-gaap Interest Paid Net
InterestPaidNet
1083000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001374328
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Cash
Cash
4664000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
56000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
759000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2008000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
86000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
10371000 usd
CY2024Q3 ftlf Sales Taxes Receivable
SalesTaxesReceivable
58000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
942000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
18099000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
431000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
121000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
143000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26314000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
13130000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
522000 usd
CY2024Q3 us-gaap Assets
Assets
58587000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4078000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3261000 usd
CY2024Q3 ftlf Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
957000 usd
CY2023Q4 ftlf Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
1026000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1861000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
892000 usd
CY2024Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
570000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
571000 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
4500000 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
4500000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
89000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12055000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10337000 usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
9664000 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
15509000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
352000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2358000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2413000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
24429000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
28310000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4598000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4598000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30699000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3417000 usd
CY2023Q4 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
-292000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
27036000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55346000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23332000 usd
us-gaap Gross Profit
GrossProfit
16069000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3359000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5399000 usd
CY2024Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
59000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1519000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000 usd
us-gaap Operating Expenses
OperatingExpenses
10341000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3182000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5728000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
269000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
598000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-93000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-422000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5306000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2306000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1490000 usd
us-gaap Net Income Loss
NetIncomeLoss
3816000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4458000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4965000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4901000
us-gaap Net Income Loss
NetIncomeLoss
3816000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
35000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-318000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-136000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-49000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3767000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
31856000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
141000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2126000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
34158000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
27036000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
344000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-136000 usd
us-gaap Net Income Loss
NetIncomeLoss
6914000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
34158000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23850000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-318000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1696000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
25249000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21388000 usd
ftlf Shares Surrendered By Former Employee
SharesSurrenderedByFormerEmployee
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
94000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-49000 usd
us-gaap Net Income Loss
NetIncomeLoss
3816000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
25249000 usd
us-gaap Net Income Loss
NetIncomeLoss
3816000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-17000 usd
us-gaap Inventory Write Down
InventoryWriteDown
35000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
94000 usd
ftlf Amortization Of Deferred Finance Costs
AmortizationOfDeferredFinanceCosts
8000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
498000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2534000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-709000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
471000 usd
ftlf Operating Lease Rightofuse Asset Net Of Amortization And Lease Liability
OperatingLeaseRightofuseAssetNetOfAmortizationAndLeaseLiability
-72000 usd
ftlf Operating Lease Rightofuse Asset Net Of Amortization And Lease Liability
OperatingLeaseRightofuseAssetNetOfAmortizationAndLeaseLiability
-60000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3570000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-60000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
71000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2772000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
17099000 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
-0 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
1825000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18984000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
12500000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5875000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5875000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11250000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2822000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4965000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13277000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4720000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8312000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
593000 usd
us-gaap Interest Paid Net
InterestPaidNet
475000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
386000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 1 - DESCRIPTION OF BUSINESS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FitLife Brands, Inc. (the “<i>Company</i>”) is a provider of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers marketed under the following brand names: (i) NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, “<i>NDS Products</i>”); (ii) iSatori, BioGenetic Laboratories, and Energize (together, the "<i>iSatori Products</i>"); (iii) Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the “<i>MRC Products</i>"); and (iv) MusclePharm.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company distributes the NDS Products principally through franchised General Nutrition Centers, Inc. (“<i>GNC</i>”) stores located both domestically and internationally and, with the launch of Metis Nutrition, through corporate GNC stores in the U.S. The iSatori Products are sold through retail locations, which include specialty and mass, as well as online directly to the end consumer. The Company distributes the MRC Products primarily online through e-commerce platforms, such as Amazon, directly to the end consumer. MusclePharm’s products are sold to both wholesale customers as well as online through various e-commerce platforms directly to the end consumer.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FitLife Brands is headquartered in Omaha, Nebraska. For more information on the Company, please go to www.fitlifebrands.com. The Company’s common stock, par value $0.01 per share (“<i>Common Stock</i>”), trades under the symbol “FTLF” on the Nasdaq Capital Market. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 2 - BASIS OF PRESENTATION</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation are included. Operating results for the three- and nine-month periods ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. Although management of the Company believes the disclosures presented herein are adequate and not misleading, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission (the “<i>SEC</i>”) on March 29, 2024. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Use of Estimates and Assumptions</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and (iii) the reported amount of net sales and expense recognized during the periods presented.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, allowance for inventory obsolescence, product returns, depreciable lives of property and equipment, allocation of purchase price from business combinations, analysis of impairment of goodwill, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15977000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13902000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
49456000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39401000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Customer and Vendor Concentration</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net sales to GNC during the three-month periods ended September 30, 2024 and 2023 represent 23% and 30% of total net revenue, respectively. Net sales to GNC during the nine-month periods ended September 30, 2024 and 2023 represent 24% and 34% of total net revenue, respectively. Gross accounts receivable attributable to GNC represented 28% and 30% of the Company’s total accounts receivable balance as of September 30, 2024 and December 31, 2023, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of September 30, 2024 and December 31, 2023, there was <span style="-sec-ix-hidden:c456"><span style="-sec-ix-hidden:c457">one</span></span> vendor that accounted for more than 10% of the Company's consolidated accounts payable. During the nine months ended September 30, 2024 and 2023, there were <span style="-sec-ix-hidden:c460"><span style="-sec-ix-hidden:c461">two</span></span> vendors that each accounted for over 10% of the Company’s inventory-related purchases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.28 pure
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2126000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1696000 usd
us-gaap Net Income Loss
NetIncomeLoss
6914000 usd
us-gaap Net Income Loss
NetIncomeLoss
3816000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4598000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4446000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4598000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4458000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
367000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
445000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
345000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
443000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4965000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4891000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4943000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4901000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.4
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Reclassifications</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain reclassifications have been made in the Company’s financial statements. Advertising and marketing expense for the three and nine months ended September 30, 2023 were previously reported as part of selling, general and administrative expense. Advertising and marketing expense is now segregated and reported separately in the accompanying statement of income and comprehensive income to conform to current period presentation. These reclassifications had no impact on earnings or stockholders’ equity.</p>
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
86000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
162000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9403000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8292000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1054000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
961000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
86000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
162000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
10371000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
9091000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
965000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
954000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
874000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
817000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
15000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
11000 usd
us-gaap Depreciation
Depreciation
57000 usd
us-gaap Depreciation
Depreciation
33000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9664000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15509000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4598000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
160000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
468000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
484000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.82
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.2
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
-0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
494000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
494000
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
7.36
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
407000
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
4.57
CY2024Q3 us-gaap Share Price
SharePrice
32.74
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12554000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.2
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
146000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.2
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
542000 usd

Files In Submission

Name View Source Status
0001437749-24-035027-index-headers.html Edgar Link pending
0001437749-24-035027-index.html Edgar Link pending
0001437749-24-035027.txt Edgar Link pending
0001437749-24-035027-xbrl.zip Edgar Link pending
ex_741593.htm Edgar Link pending
ex_741594.htm Edgar Link pending
ex_741595.htm Edgar Link pending
ex_741596.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ftlf-20240930.xsd Edgar Link pending
ftlf-20240930_cal.xml Edgar Link unprocessable
ftlf-20240930_lab.xml Edgar Link unprocessable
ftlf-20240930_pre.xml Edgar Link unprocessable
ftlf20240930_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
ftlf20240930_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ftlf-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable